TY - JOUR
T1 - Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
AU - Arai, Eri
AU - Chiku, Suenori
AU - Mori, Taisuke
AU - Gotoh, Masahiro
AU - Nakagawa, Tohru
AU - Fujimoto, Hiroyuki
AU - Kanai, Yae
N1 - Funding Information:
Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio); Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund; Grants-in-Aid for Scientific Research (B) and for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS).
PY - 2012/8
Y1 - 2012/8
N2 - To clarify the significance of DNA methylation alterations during renal carcinogenesis, methylome analysis using single-CpG-resolution Infinium array was performed on 29 normal renal cortex tissue (C) samples, 107 non-cancerous renal cortex tissue (N) samples obtained from patients with clear cell renal cell carcinomas (RCCs) and 109 tumorous tissue (T) samples. DNA methylation levels at 4830 CpG sites were already altered in N samples compared with C samples. Unsupervised hierarchical clustering analysis based on DNA methylation levels at the 801 CpG sites, where DNA methylation alterations had occurred in N samples and were inherited by and strengthened in T samples, clustered clear cell RCCs into Cluster A (n = 90) and Cluster B (n = 14). Clinicopathologically aggressive tumors were accumulated in Cluster B, and the cancer-free and overall survival rates of patients in this cluster were significantly lower than those of patients in Cluster A. Clear cell RCCs in Cluster B were characterized by accumulation of DNA hypermethylation on CpG islands and considered to be CpG island methylator phenotype (CIMP)-positive cancers. DNA hypermethylation of the CpG sites on the FAM150A, GRM6, ZNF540, ZFP42, ZNF154, RIMS4, PCDHAC1, KHDRBS2, ASCL2, KCNQ1, PRAC, WNT3A, TRH, FAM78A, ZNF671, SLC13A5 and NKX6-2 genes became hallmarks of CIMP in RCCs. On the other hand, Cluster A was characterized by genome-wide DNA hypomethylation. These data indicated that DNA methylation alterations at precancerous stages may determine tumor aggressiveness and patient outcome. Accumulation of DNA hypermethylation on CpG islands and genome-wide DNA hypomethylation may each underlie distinct pathways of renal carcinogenesis. Abbreviations: BAMCAbacterial artificial chromosome array-based methylated CpG island amplification. Cnormal renal cortex tissue obtained from patients without any primary renal tumor. CIMPCpG island methylator phenotype. HCChepatocellular carcinoma. Nnon-cancerous renal cortex tissue obtained from patients with clear cell renal cell carcinomas. NCBINational Center for Biotechnology Information. RCCrenal cell carcinoma. Ttumorous tissue. TNMTumor-Node-Metastasis.
AB - To clarify the significance of DNA methylation alterations during renal carcinogenesis, methylome analysis using single-CpG-resolution Infinium array was performed on 29 normal renal cortex tissue (C) samples, 107 non-cancerous renal cortex tissue (N) samples obtained from patients with clear cell renal cell carcinomas (RCCs) and 109 tumorous tissue (T) samples. DNA methylation levels at 4830 CpG sites were already altered in N samples compared with C samples. Unsupervised hierarchical clustering analysis based on DNA methylation levels at the 801 CpG sites, where DNA methylation alterations had occurred in N samples and were inherited by and strengthened in T samples, clustered clear cell RCCs into Cluster A (n = 90) and Cluster B (n = 14). Clinicopathologically aggressive tumors were accumulated in Cluster B, and the cancer-free and overall survival rates of patients in this cluster were significantly lower than those of patients in Cluster A. Clear cell RCCs in Cluster B were characterized by accumulation of DNA hypermethylation on CpG islands and considered to be CpG island methylator phenotype (CIMP)-positive cancers. DNA hypermethylation of the CpG sites on the FAM150A, GRM6, ZNF540, ZFP42, ZNF154, RIMS4, PCDHAC1, KHDRBS2, ASCL2, KCNQ1, PRAC, WNT3A, TRH, FAM78A, ZNF671, SLC13A5 and NKX6-2 genes became hallmarks of CIMP in RCCs. On the other hand, Cluster A was characterized by genome-wide DNA hypomethylation. These data indicated that DNA methylation alterations at precancerous stages may determine tumor aggressiveness and patient outcome. Accumulation of DNA hypermethylation on CpG islands and genome-wide DNA hypomethylation may each underlie distinct pathways of renal carcinogenesis. Abbreviations: BAMCAbacterial artificial chromosome array-based methylated CpG island amplification. Cnormal renal cortex tissue obtained from patients without any primary renal tumor. CIMPCpG island methylator phenotype. HCChepatocellular carcinoma. Nnon-cancerous renal cortex tissue obtained from patients with clear cell renal cell carcinomas. NCBINational Center for Biotechnology Information. RCCrenal cell carcinoma. Ttumorous tissue. TNMTumor-Node-Metastasis.
UR - http://www.scopus.com/inward/record.url?scp=84865339838&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865339838&partnerID=8YFLogxK
U2 - 10.1093/carcin/bgs177
DO - 10.1093/carcin/bgs177
M3 - Article
C2 - 22610075
AN - SCOPUS:84865339838
SN - 0143-3334
VL - 33
SP - 1487
EP - 1493
JO - Carcinogenesis
JF - Carcinogenesis
IS - 8
ER -